Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Correctional Health Care
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by LaForest, J. E.
Right arrow Articles by Algozzine, T. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LaForest, J. E.
Right arrow Articles by Algozzine, T. W.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

An Evaluation of Cholesterol Management Within a State Correctional System

Judith E. LaForest, RPh, MS

Thomas W. Algozzine, PharmD, BCPS

Pfizer, Inc., Manchester, New Hampshire; 88 Tiffany Lane, Manchester, NH 03104; thomas.algozzine{at}pfizer.com

The objectives of this evaluation were to analyze the efficacy of cholesterol lowering therapy as outlined by the National Cholesterol Education Program (NCEP) guidelines and to determine the cost effectiveness of treating hyperlipidemia in the incarcerated patient. A retrospective chart review was conducted of 100 randomly selected charts identified through the pharmacy claims data. Criteria for inclusion were that patients had received at least 60 days of therapy and had a baseline LDL-C prior to drug initiation. Seventy-nine patients met these criteria. Overall, 71% (56) of patients achieved NCEP 2 goal LDL-C. Forty-five percent of patients with coronary heart disease (CHD) achieved a goal LDL-C of less than 100 mg/dL. Ninety-five percent of patients were compliant with their therapy (at least five refills in six months). It was hypothesized that over five years the system will prevent one CHD patient from having a coronary procedure and two fatal coronary events in the population reviewed. The results of this review reinforce the importance of effectively managing hyperlipidemia in a state correctional system.

Journal of Correctional Health Care, Vol. 10, No. 1, 75-87 (2003)
DOI: 10.1177/107834580301000107
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?